Is ivermectin surviving expectations in residual malaria control?

IF 36.4 1区医学 Q1 INFECTIOUS DISEASES Lancet Infectious Diseases Pub Date : 2024-11-14 DOI:10.1016/s1473-3099(24)00652-2

Karine Mouline, Carlo Costantini

引用次数: 0

Abstract

No Abstract

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

伊维菌素在控制残余疟疾方面是否能达到预期效果？

无摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Lancet Infectious Diseases 医学-传染病学

CiteScore

60.90

自引率

0.70%

发文量

1064

审稿时长

6-12 weeks

期刊介绍： The Lancet Infectious Diseases was launched in August, 2001, and is a lively monthly journal of original research, review, opinion, and news covering international issues relevant to clinical infectious diseases specialists worldwide.The infectious diseases journal aims to be a world-leading publication, featuring original research that advocates change or sheds light on clinical practices related to infectious diseases. The journal prioritizes articles with the potential to impact clinical practice or influence perspectives. Content covers a wide range of topics, including anti-infective therapy and immunization, bacterial, viral, fungal, and parasitic infections, emerging infectious diseases, HIV/AIDS, malaria, tuberculosis, mycobacterial infections, infection control, infectious diseases epidemiology, neglected tropical diseases, and travel medicine. Informative reviews on any subject linked to infectious diseases and human health are also welcomed.